Mesa Laboratories Has Delayed The Release Of Its Fourth-quarter And Fiscal Year 2024 Financial Results, Originally Scheduled For Today

5/31/24 6:04:18 AM ET

Industrial Machinery/Components

Industrials

Get the next $MLAB alert in real time by email

The postponement is due to the ongoing year-end audit, which is finalizing calculations and technical accounting for previously announced impairments of long-lived assets and goodwill in the Clinical Genomics and Biopharmaceutical Development divisions, as well as the purchase accounting for the acquisition of GKE.

Mesa's Form 10-K filing deadline with the SEC is June 14, 2024.

Get the next $MLAB alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MLAB

Date	Price Target	Rating	Analyst
8/28/2024	$120.00	Underweight	Wells Fargo
1/4/2024	$100.00 → $125.00	In-line → Outperform	Evercore ISI

More analyst ratings

$MLAB
Leadership Updates

Live Leadership Updates

Mesa Laboratories Appoints Mark Capone to its Board of Directors
LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa
1/8/24 8:00:00 AM ET
$MLAB
Industrial Machinery/Components
Industrials
Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director
LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes
11/4/22 3:49:04 PM ET
$MLAB
Industrial Machinery/Components
Industrials
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the "Board"), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of Corning, Incorporated and retired on May 2, 2022. With Mr. Tripeny's appointment, the Mesa Laboratories, Inc. Board of Directors will be comprised of eight directors, six of whom are independent. Mr. Tripeny is likely to be appointed to the Audit Committee and brings extensive financial experience to the Board. The Board is committed to ongoing director refreshment and continues to consider new, qualified independent
6/27/22 8:01:00 AM ET
$MLAB
Industrial Machinery/Components
Industrials

MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in
10/2/24 2:00:00 PM ET
$MLAB
Industrial Machinery/Components
Industrials
MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, Colo, July 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 16, 2024, to shareholders of record at the close of business on August 30, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in
7/8/24 2:00:00 PM ET
$MLAB
Industrial Machinery/Components
Industrials
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., April 04, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 14, 2024, to shareholders of record at the close of business on May 31, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p
4/4/24 6:24:00 PM ET
$MLAB
Industrial Machinery/Components
Industrials

Mesa Labs Announces Second Quarter Results
LAKEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter ("2Q25") ended September 30, 2024 (amounts in thousands). Second quarter FY 2025 compared to second quarter FY 2024: Revenues increased 8.8%Non-GAAP core organic revenues¹ decline was 2.8%Operating income increased 5,947% to $3,508 Non-GAAP adjusted operating income excluding unusual items² increased 18.9% and was 24.8% as a percentage of revenues We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"), Cl
11/7/24 8:00:27 AM ET
$MLAB
Industrial Machinery/Components
Industrials
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in
10/2/24 2:00:00 PM ET
$MLAB
Industrial Machinery/Components
Industrials
Mesa Labs Announces First Quarter Results
LAKEWOOD, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter ("1Q25") ended June 30, 2024 (amounts in thousands). First quarter FY 2025 compared to first quarter FY 2024: Revenues increased 14.9%Non-GAAP core organic revenues1 growth was 3.0%Operating income increased 940%Non-GAAP adjusted operating income excluding unusual items2 increased 47.0% and was 26.4% as a percentage of revenues We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"), Clinical Genomics ("
8/5/24 8:00:59 AM ET
$MLAB
Industrial Machinery/Components
Industrials

Mesa Laboratories Has Delayed The Release Of Its Fourth-quarter And Fiscal Year 2024 Financial Results, Originally Scheduled For Today

Chat with this insight

Recent Analyst Ratings for $MLAB

$MLAB Market Insights

Live Market Insights

Evercore ISI Group Maintains Outperform on Mesa Laboratories, Lowers Price Target to $106

Mesa Laboratories shares are trading higher after the company reported better-than-expected Q4 sales results.

Mesa Laboratories Q4 2024 GAAP EPS $(47.20) May Not Be Comparable To $(0.12) Estimate, Sales $58.904M Beat $55.275M Estimate

$MLAB SEC Filings

SEC Form 10-Q filed by Mesa Laboratories Inc.

Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Mesa Laboratories Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

$MLAB Leadership Updates

Live Leadership Updates

Mesa Laboratories Appoints Mark Capone to its Board of Directors

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

$MLAB Financials

Live finance-specific insights

$MLAB Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$MLAB Large Ownership Changes

This live feed shows all institutional transactions in real time.

$MLAB Press Releases

Fastest customizable press release news feed in the world

MESA LABS DECLARES QUARTERLY DIVIDEND

MESA LABS DECLARES QUARTERLY DIVIDEND

MESA LABS DECLARES QUARTERLY DIVIDEND

Wells Fargo initiated coverage on Mesa Laboratories with a new price target

Mesa Laboratories upgraded by Evercore ISI with a new price target

Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

Mesa Labs Announces Second Quarter Results

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Labs Announces First Quarter Results

$MLAB Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Owens Gary M was granted 11,559 shares and sold $571,736 worth of shares (5,069 units at $112.79), increasing direct ownership by 18% to 43,337 units (SEC Form 4)

SVP Operations Archbold Brian David sold $187,375 worth of shares (1,499 units at $125.00), closing all direct ownership in the company (SEC Form 4)

CFO Sakys John converted options into 1,037 shares and covered exercise/tax liability with 454 shares, increasing direct ownership by 5% to 12,046 units (SEC Form 4)

Recent Analyst Ratings for
$MLAB

$MLAB
Market Insights

$MLAB
SEC Filings

$MLAB
Leadership Updates

$MLAB
Financials

$MLAB
Analyst Ratings

$MLAB
Large Ownership Changes

$MLAB
Press Releases

$MLAB
Insider Trading